共 9 条
[1]
Inhibition of T cell–dependent and RANKL‐dependent osteoclastogenic processes associated with high levels of bone mass in interleukin‐15 receptor–deficient mice.[J].SouadDjaafar;Dominique D.Pierroz;RachelChicheportiche;Xin XiaoZheng;Serge L.Ferrari;SylvieFerrari‐Lacraz.Arthritis & Rheumatism.2010, 11
[2]
TNF-α and IL-1β inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.[J].J. Ding;O. Ghali;P. Lencel;O. Broux;C. Chauveau;J.C. Devedjian;P. Hardouin;D. Magne.Life Sciences.2009, 15
[4]
Emerging treatments for postmenopausal osteoporosis – focus on denosumab.[J].Piet Geusens.Clinical Interventions in Aging.2009, defa
[6]
RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice.[J].Vaira; Sergio;Alhawagri; Muhammad;Anwisye; Imani;Kitaura; Hideki;Faccio; Roberta;Novack; Deborah Veis.Journal of Clinical Investigation.2008, 6
[7]
OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism.[J].Matthew C. Walsh;Nacksung Kim;Yuho Kadono;Jaerang Rho;Soo Young Lee;Joseph Lorenzo;Yongwon Choi.Annual Review of Immunology.2006, 0
[9]
Missing Pieces in the NF-κB Puzzle.[J].Sankar Ghosh;Michael Karin.Cell.2002, 2

